Sign Up Today and Learn More About Tuft & Needle Stock
Invest in or calculate the value of your shares in Tuft & Needle or other pre-IPO companies through EquityZen's platform.
Tuft & Needle Stock (TUNE)
Pioneer of the universally comfortable mattress that's #1 rated online. No gimmicks, no sales tactics, 100-Night Sleep Trial & easy returns.
About Tuft & Needle Stock
Founded
2012
Headquarters
Phoenix, AZ, US
Industries
Software, Artificial Intelligence, Financial Services
Tuft & Needle is a Phoenix-based company that pioneered the disruption of the mattress industry. Founded in 2012 by two software engineers from Silicon Valley that were fed up with their mattress shopping experience, T&N is leading the revolution against unfair mattress markups, commission-based sales models, and information asymmetry by creating exceptional, honestly-priced products.
Tuft & Needle Press Mentions
Stay in the know about the latest news on Tuft & Needle
Tuft & Needle Mint Mattress review: A cooling, supportive mattress that's perfect for hot sleepers
businessinsider • May 05, 2025
Tuft & Needle Promo Codes: 20% Off | May 2025
wired • May 01, 2025
Adjustable Beds Mattress Market to Reach 56.56 USD Bn by 2032 with 2.5% CAGR Driven by increasing healthcare provision
einpresswire • Feb 25, 2025
Tuft & Needle Original Hybrid mattress review: A very comfortable, breathable, and responsive mid-range bed
businessinsider • Jan 24, 2025
Tuft & Needle Coupons for November 2024
techradar • Nov 26, 2024
Tuft & Needle Management
Leadership team at Tuft & Needle
Co-Founder
JT Marino
CEO
Piet Jan de Bruin
Join now and verify your accreditation status to gain access to:
- Tuft & Needle Current Valuation
- Tuft & Needle Stock Price
- Tuft & Needle Management
- Available deals in Tuft & Needle and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Tuft & Needle Cap Table and Funding History by Share Class and Liquidity Preferences
- Tuft & Needle Revenue and Financials
- Tuft & Needle Highlights
- Tuft & Needle Business Model
- Tuft & Needle Risk Factors
- Tuft & Needle Research Report from SACRA Research
Trading Tuft & Needle Stock
How to invest in Tuft & Needle stock?
Accredited investors can buy pre-IPO stock in companies like Tuft & Needle through EquityZen funds. These investments are made available by existing Tuft & Needle shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Tuft & Needle stock?
Shareholders can sell their Tuft & Needle stock through EquityZen's private company marketplace. EquityZen's network includes over 380K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 47K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
